Rezaee-Zavareh, Mohammad Saeid
Hwang, Soo Young
Kim, Naomy
Adetyan, Hasmik
Tran, Nguyen H.
Yang, Ju Dong
Funding for this research was provided by:
National Institute of Minority Health and Health Disparity K23 Career Development Grant (K23MD017217-01A1)
NCI (NCI K08 CA259534)
Article History
Received: 22 January 2025
Accepted: 15 July 2025
First Online: 28 July 2025
Declarations
:
: Not applicable.
: NHT has received funding (directed to Mayo Clinic Foundation) or has served as consultant for AstraZeneca, DAVA oncology, Elevar, Exact Sciences, Exelixis, Genentech, Ipsen, QED/Helsinn Therapeutics. JDY provides a consulting service for AstraZeneca, Eisai, Exact Sciences, Exelixis, Fujifilm Medical Sciences, and Gilead Sciences. Other authors declare no conflict of interest.